News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Glucon Appoints New U.S.-based CEO Mr. Daniel Goldberger
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Glucon (www.glucon.com), developer of a continuous, noninvasive, blood glucose monitoring technology for home and clinical use, announced today the appointment of Mr. Daniel Goldberger as the Company's new CEO.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Psychedelics
Delix raises $100M to advance at-home psychedelic without hallucinogenic effects
November 10, 2026
·
2 min read
·
Tristan Manalac
Job Trends
BioSpace
2027 Best Places to Work shines light on most admired employers
November 10, 2026
·
7 min read
·
Angela Gabriel
GLP-1
FDA orders class-wide GLP-1 label update to include potential risk for rare eye disease
November 9, 2026
·
2 min read
·
Gabrielle Masson
Infectious disease
Vir’s hepatitis delta combo tamps down virus as Gilead showdown looms
November 9, 2026
·
3 min read
·
Gabrielle Masson